首页> 外文期刊>Ophthalmic Surgery and Lasers >Implantation of second glaucoma drainage devices after failure of primary devices.
【24h】

Implantation of second glaucoma drainage devices after failure of primary devices.

机译:主装置失效后植入第二个青光眼引流装置。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: To evaluate the efficacy and safety of implantation of a second glaucoma drainage device for eyes that have failed a primary device. PATIENTS AND METHODS: Medical records of patients receiving a primary glaucoma drainage device at Bascom Palmer Eye Institute from January 1987 to October 1998 were reviewed, of which 18 eyes of 18 patients were studied. Patients failing a primary glaucoma drainage procedure and receiving a second glaucoma drainage device were included in this study. The second eye in the same patient was excluded if a second drainage implant was required. All patients received a second device in a standardized fashion with the drainage tube inserted in the anterior chamber. Main outcome measures included: visual acuity, intraocular pressure (IOP), antiglaucomatous medication, length of follow up, and surface area of glaucoma drainage device. Success was defined as an IOP less than or equal to 21 mm Hg with or without medications, and at least a 20% reduction in IOP, without the need for additional glaucoma procedures. RESULTS: The mean postoperative IOP (19.6 +/- 9.4 mm Hg; range, 8-50 mm Hg) was significantly (P = 0.006) lower than the mean preoperative IOP (29.5 +/- 8.1 mm Hg; range, 20-52 mm Hg) at last follow up (mean 19.6 +/- 13.6 months; range, 6-47 months). The mean number of postoperative antiglaucomatous medications (2.2 +/- 1.2; range 0-4) was statistically similar (P = 0.2) to mean preoperative number of antiglaucomatous medications (2.6 +/- 1.2, range 1-4). Using Kaplan-Meier estimates, successful IOP reduction was observed in 89%, 83%, 63%, and 37% of eyes at 6 months, 1, 2, and 3 years, respectively. Four patients (21%) had a decline in visual acuity. CONCLUSIONS: Implantation of secondary glaucoma drainage devices may be useful in eyes that have failed primary devices.
机译:背景与目的:评估第二个青光眼引流装置对主要装置失败的眼睛的植入效果和安全性。病人和方法:回顾了1987年1月至1998年10月在Bascom Palmer眼科研究所接受青光眼引流器的患者的病历,对其中18例患者的18只眼进行了研究。原发性青光眼引流手术失败并接受第二次青光眼引流装置的患者包括在本研究中。如果需要第二枚引流植入物,则排除同一患者的第二只眼睛。所有患者均以标准化方式接受第二个装置,引流管插入前房。主要的预后指标包括:视力,眼压(IOP),抗青光眼药物,随访时间和青光眼引流装置的表面积。成功的定义是在有或没有药物的情况下,眼压小于或等于21毫米汞柱,且眼压降低至少20%,而无需其他青光眼手术。结果:术后平均眼压(19.6 +/- 9.4 mm Hg;范围8-50 mm Hg)显着(P = 0.006)低于平均术前眼压(29.5 +/- 8.1 mm Hg;范围20-52)最后一次随访(平均19.6 +/- 13.6个月;范围:6-47个月)。术后平均抗青光眼用药数量(2.2 +/- 1.2;范围0-4)与术前平均抗青光眼用药数量(2.6 +/- 1.2,范围1-4)在统计学上相似(P = 0.2)。使用Kaplan-Meier估计,分别在6个月,1、2和3年时,分别成功地减少了89%,83%,63%和37%的眼睛的IOP。四名患者(21%)的视力下降。结论:继发性青光眼引流装置的植入可能对主要装置失效的眼睛有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号